CG Oncology (CGON) Current Assets (2023 - 2026)

CG Oncology's Current Assets history runs 4 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• Quarterly Current Assets rose 57.18% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 57.18% YoY) and the FY2025 annual result came in at $759.5 million, up 0.7% from the prior year.
• Current Assets was $1.1 billion for Q1 2026 at CG Oncology, up from $759.5 million in the prior quarter.
• Across five years, Current Assets topped out at $1.1 billion in Q1 2026 and bottomed at $194.1 million in Q4 2023.
• A 4-year average of $657.5 million and a median of $684.4 million in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets jumped 288.52% — and 2025, when it advanced 0.7%.
• CG Oncology's Current Assets stood at $194.1 million in 2023, then soared by 288.52% to $754.2 million in 2024, then rose by 0.7% to $759.5 million in 2025, then jumped by 45.12% to $1.1 billion in 2026.
• Business Quant data shows CGON's Current Assets at $1.1 billion in Q1 2026, $759.5 million in Q4 2025, and $695.8 million in Q3 2025.